TITO R MENDOZA to Glioblastoma
This is a "connection" page, showing publications TITO R MENDOZA has written about Glioblastoma.
Connection Strength
0.099
-
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol. 2013 Nov 10; 31(32):4076-84.
Score: 0.054
-
The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011 Jul 15; 117(14):3222-8.
Score: 0.045